Lung Adenocarcinoma Harboring <i>EGFR</i> Kinase Domain Duplication (<i>EGFR</i>-KDD) Confers Sensitivity to Osimertinib and Nivolumab: A Case Report. Here, EGFR is linked to lung adenocarcinoma.